JPRN-UMIN000017410Completed未知
Safety and Efficacy of Protocol for Shortening the Duration of Dual Antiplatelet Therapy after Second and Third Generation Drug Eluting Stent Implantation in Patients Administered Oral Anticoagulant Agent - Safety and Efficacy of Protocol for Shortening the Duration of Dual Antiplatelet Therapy after Second and Third Generation Drug Eluting Stent Implantation in Patients Administered Oral Anticoagulant Agent
Sendai Kousei Hospital0 sites285 target enrollmentStarted: May 7, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 285
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Patients who could not tolerate antiplatelet therapy or anticoagulation therapy 2. Patients who appeared to be inappropriate for this study, determined by the investigators
Investigators
Similar Trials
Recruiting
Phase 4
The investigation of safety and efficacy of short hydration GC therapy in metastatic urothelial carcinoma patientsadvanced or metastatic urothelial carcinoma patientsJPRN-UMIN000032901agoya City University Graduate School of Medical Sciences10
Not yet recruiting
Phase 3
Evaluation of the Safety and Efficacy of Short-term A 002 Treatment in Subjects with Acute Coronary SyndromesHeart AttackHeart Disease10082206NL-OMON34504Anthera Pharmaceuticals, Inc576
Active, not recruiting
Not Applicable
Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndromes - VISTA-16Treatment of patients with Acute Coronary Syndromes (ACS)MedDRA version: 12.1Level: LLTClassification code 10051592Term: Acute coronary syndromeEUCTR2009-016812-18-CZAnthera Pharmaceuticals, Inc.6,504
Active, not recruiting
Not Applicable
Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndromes - VISTA-16Treatment of patients with Acute Coronary Syndromes (ACS)MedDRA version: 12.1Level: LLTClassification code 10051592Term: Acute coronary syndromeEUCTR2009-016812-18-DEAnthera Pharmaceuticals, Inc.6,504
Active, not recruiting
Not Applicable
Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndromes (VISTA-16) - VISTA-16Acute Coronary SyndromesMedDRA version: 9.1Level: LLTClassification code 10051592EUCTR2009-016812-18-ITANTHERA PHARMACEUTICALS6,504